Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Minimal Residual Disease (MRD) Testing Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Flow Cytometry
1.2.3 Polymerase Chain Reaction
1.2.4 Next-generation Sequencing
1.2.5 Liquid Biopsies
1.3 Market by Application
1.3.1 Global Minimal Residual Disease (MRD) Testing Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Specialty Clinics
1.3.3 Hospitals
1.3.4 Research Institutions
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Minimal Residual Disease (MRD) Testing Market Perspective (2018-2033)
2.2 Minimal Residual Disease (MRD) Testing Growth Trends by Region
2.2.1 Global Minimal Residual Disease (MRD) Testing Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Minimal Residual Disease (MRD) Testing Historic Market Size by Region (2018-2023)
2.2.3 Minimal Residual Disease (MRD) Testing Forecasted Market Size by Region (2024-2033)
2.3 Minimal Residual Disease (MRD) Testing Market Dynamics
2.3.1 Minimal Residual Disease (MRD) Testing Industry Trends
2.3.2 Minimal Residual Disease (MRD) Testing Market Drivers
2.3.3 Minimal Residual Disease (MRD) Testing Market Challenges
2.3.4 Minimal Residual Disease (MRD) Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Minimal Residual Disease (MRD) Testing Players by Revenue
3.1.1 Global Top Minimal Residual Disease (MRD) Testing Players by Revenue (2018-2023)
3.1.2 Global Minimal Residual Disease (MRD) Testing Revenue Market Share by Players (2018-2023)
3.2 Global Minimal Residual Disease (MRD) Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Minimal Residual Disease (MRD) Testing Revenue
3.4 Global Minimal Residual Disease (MRD) Testing Market Concentration Ratio
3.4.1 Global Minimal Residual Disease (MRD) Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Minimal Residual Disease (MRD) Testing Revenue in 2022
3.5 Minimal Residual Disease (MRD) Testing Key Players Head office and Area Served
3.6 Key Players Minimal Residual Disease (MRD) Testing Product Solution and Service
3.7 Date of Enter into Minimal Residual Disease (MRD) Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Minimal Residual Disease (MRD) Testing Breakdown Data by Type
4.1 Global Minimal Residual Disease (MRD) Testing Historic Market Size by Type (2018-2023)
4.2 Global Minimal Residual Disease (MRD) Testing Forecasted Market Size by Type (2024-2033)
5 Minimal Residual Disease (MRD) Testing Breakdown Data by Application
5.1 Global Minimal Residual Disease (MRD) Testing Historic Market Size by Application (2018-2023)
5.2 Global Minimal Residual Disease (MRD) Testing Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Minimal Residual Disease (MRD) Testing Market Size (2018-2033)
6.2 North America Minimal Residual Disease (MRD) Testing Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Minimal Residual Disease (MRD) Testing Market Size by Country (2018-2023)
6.4 North America Minimal Residual Disease (MRD) Testing Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Minimal Residual Disease (MRD) Testing Market Size (2018-2033)
7.2 Europe Minimal Residual Disease (MRD) Testing Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Minimal Residual Disease (MRD) Testing Market Size by Country (2018-2023)
7.4 Europe Minimal Residual Disease (MRD) Testing Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Minimal Residual Disease (MRD) Testing Market Size (2018-2033)
8.2 Asia-Pacific Minimal Residual Disease (MRD) Testing Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Minimal Residual Disease (MRD) Testing Market Size by Region (2018-2023)
8.4 Asia-Pacific Minimal Residual Disease (MRD) Testing Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Minimal Residual Disease (MRD) Testing Market Size (2018-2033)
9.2 Latin America Minimal Residual Disease (MRD) Testing Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Minimal Residual Disease (MRD) Testing Market Size by Country (2018-2023)
9.4 Latin America Minimal Residual Disease (MRD) Testing Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Minimal Residual Disease (MRD) Testing Market Size (2018-2033)
10.2 Middle East & Africa Minimal Residual Disease (MRD) Testing Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Minimal Residual Disease (MRD) Testing Market Size by Country (2018-2023)
10.4 Middle East & Africa Minimal Residual Disease (MRD) Testing Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Sysmex Corporation
11.1.1 Sysmex Corporation Company Detail
11.1.2 Sysmex Corporation Business Overview
11.1.3 Sysmex Corporation Minimal Residual Disease (MRD) Testing Introduction
11.1.4 Sysmex Corporation Revenue in Minimal Residual Disease (MRD) Testing Business (2018-2023)
11.1.5 Sysmex Corporation Recent Development
11.2 Natera
11.2.1 Natera Company Detail
11.2.2 Natera Business Overview
11.2.3 Natera Minimal Residual Disease (MRD) Testing Introduction
11.2.4 Natera Revenue in Minimal Residual Disease (MRD) Testing Business (2018-2023)
11.2.5 Natera Recent Development
11.3 Asuragen
11.3.1 Asuragen Company Detail
11.3.2 Asuragen Business Overview
11.3.3 Asuragen Minimal Residual Disease (MRD) Testing Introduction
11.3.4 Asuragen Revenue in Minimal Residual Disease (MRD) Testing Business (2018-2023)
11.3.5 Asuragen Recent Development
11.4 Quest Diagnostics
11.4.1 Quest Diagnostics Company Detail
11.4.2 Quest Diagnostics Business Overview
11.4.3 Quest Diagnostics Minimal Residual Disease (MRD) Testing Introduction
11.4.4 Quest Diagnostics Revenue in Minimal Residual Disease (MRD) Testing Business (2018-2023)
11.4.5 Quest Diagnostics Recent Development
11.5 Mission Bio
11.5.1 Mission Bio Company Detail
11.5.2 Mission Bio Business Overview
11.5.3 Mission Bio Minimal Residual Disease (MRD) Testing Introduction
11.5.4 Mission Bio Revenue in Minimal Residual Disease (MRD) Testing Business (2018-2023)
11.5.5 Mission Bio Recent Development
11.6 LabCorp
11.6.1 LabCorp Company Detail
11.6.2 LabCorp Business Overview
11.6.3 LabCorp Minimal Residual Disease (MRD) Testing Introduction
11.6.4 LabCorp Revenue in Minimal Residual Disease (MRD) Testing Business (2018-2023)
11.6.5 LabCorp Recent Development
11.7 Guardant Health
11.7.1 Guardant Health Company Detail
11.7.2 Guardant Health Business Overview
11.7.3 Guardant Health Minimal Residual Disease (MRD) Testing Introduction
11.7.4 Guardant Health Revenue in Minimal Residual Disease (MRD) Testing Business (2018-2023)
11.7.5 Guardant Health Recent Development
11.8 NeoGenomics Laboratories
11.8.1 NeoGenomics Laboratories Company Detail
11.8.2 NeoGenomics Laboratories Business Overview
11.8.3 NeoGenomics Laboratories Minimal Residual Disease (MRD) Testing Introduction
11.8.4 NeoGenomics Laboratories Revenue in Minimal Residual Disease (MRD) Testing Business (2018-2023)
11.8.5 NeoGenomics Laboratories Recent Development
11.9 ARUP Laboratories
11.9.1 ARUP Laboratories Company Detail
11.9.2 ARUP Laboratories Business Overview
11.9.3 ARUP Laboratories Minimal Residual Disease (MRD) Testing Introduction
11.9.4 ARUP Laboratories Revenue in Minimal Residual Disease (MRD) Testing Business (2018-2023)
11.9.5 ARUP Laboratories Recent Development
11.10 NeoGenomics , Inc
11.10.1 NeoGenomics , Inc Company Detail
11.10.2 NeoGenomics , Inc Business Overview
11.10.3 NeoGenomics , Inc Minimal Residual Disease (MRD) Testing Introduction
11.10.4 NeoGenomics , Inc Revenue in Minimal Residual Disease (MRD) Testing Business (2018-2023)
11.10.5 NeoGenomics , Inc Recent Development
11.11 Opko Health
11.11.1 Opko Health Company Detail
11.11.2 Opko Health Business Overview
11.11.3 Opko Health Minimal Residual Disease (MRD) Testing Introduction
11.11.4 Opko Health Revenue in Minimal Residual Disease (MRD) Testing Business (2018-2023)
11.11.5 Opko Health Recent Development
11.12 Bio-Rad Laboratories
11.12.1 Bio-Rad Laboratories Company Detail
11.12.2 Bio-Rad Laboratories Business Overview
11.12.3 Bio-Rad Laboratories Minimal Residual Disease (MRD) Testing Introduction
11.12.4 Bio-Rad Laboratories Revenue in Minimal Residual Disease (MRD) Testing Business (2018-2023)
11.12.5 Bio-Rad Laboratories Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Minimal Residual Disease (MRD) Testing Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Flow Cytometry
Table 3. Key Players of Polymerase Chain Reaction
Table 4. Key Players of Next-generation Sequencing
Table 5. Key Players of Liquid Biopsies
Table 6. Global Minimal Residual Disease (MRD) Testing Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 7. Global Minimal Residual Disease (MRD) Testing Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 8. Global Minimal Residual Disease (MRD) Testing Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global Minimal Residual Disease (MRD) Testing Market Share by Region (2018-2023)
Table 10. Global Minimal Residual Disease (MRD) Testing Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 11. Global Minimal Residual Disease (MRD) Testing Market Share by Region (2024-2033)
Table 12. Minimal Residual Disease (MRD) Testing Market Trends
Table 13. Minimal Residual Disease (MRD) Testing Market Drivers
Table 14. Minimal Residual Disease (MRD) Testing Market Challenges
Table 15. Minimal Residual Disease (MRD) Testing Market Restraints
Table 16. Global Minimal Residual Disease (MRD) Testing Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global Minimal Residual Disease (MRD) Testing Market Share by Players (2018-2023)
Table 18. Global Top Minimal Residual Disease (MRD) Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Minimal Residual Disease (MRD) Testing as of 2022)
Table 19. Ranking of Global Top Minimal Residual Disease (MRD) Testing Companies by Revenue (US$ Million) in 2022
Table 20. Global 5 Largest Players Market Share by Minimal Residual Disease (MRD) Testing Revenue (CR5 and HHI) & (2018-2023)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Minimal Residual Disease (MRD) Testing Product Solution and Service
Table 23. Date of Enter into Minimal Residual Disease (MRD) Testing Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Minimal Residual Disease (MRD) Testing Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global Minimal Residual Disease (MRD) Testing Revenue Market Share by Type (2018-2023)
Table 27. Global Minimal Residual Disease (MRD) Testing Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 28. Global Minimal Residual Disease (MRD) Testing Revenue Market Share by Type (2024-2033)
Table 29. Global Minimal Residual Disease (MRD) Testing Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global Minimal Residual Disease (MRD) Testing Revenue Market Share by Application (2018-2023)
Table 31. Global Minimal Residual Disease (MRD) Testing Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 32. Global Minimal Residual Disease (MRD) Testing Revenue Market Share by Application (2024-2033)
Table 33. North America Minimal Residual Disease (MRD) Testing Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 34. North America Minimal Residual Disease (MRD) Testing Market Size by Country (2018-2023) & (US$ Million)
Table 35. North America Minimal Residual Disease (MRD) Testing Market Size by Country (2024-2033) & (US$ Million)
Table 36. Europe Minimal Residual Disease (MRD) Testing Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 37. Europe Minimal Residual Disease (MRD) Testing Market Size by Country (2018-2023) & (US$ Million)
Table 38. Europe Minimal Residual Disease (MRD) Testing Market Size by Country (2024-2033) & (US$ Million)
Table 39. Asia-Pacific Minimal Residual Disease (MRD) Testing Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 40. Asia-Pacific Minimal Residual Disease (MRD) Testing Market Size by Region (2018-2023) & (US$ Million)
Table 41. Asia-Pacific Minimal Residual Disease (MRD) Testing Market Size by Region (2024-2033) & (US$ Million)
Table 42. Latin America Minimal Residual Disease (MRD) Testing Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 43. Latin America Minimal Residual Disease (MRD) Testing Market Size by Country (2018-2023) & (US$ Million)
Table 44. Latin America Minimal Residual Disease (MRD) Testing Market Size by Country (2024-2033) & (US$ Million)
Table 45. Middle East & Africa Minimal Residual Disease (MRD) Testing Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 46. Middle East & Africa Minimal Residual Disease (MRD) Testing Market Size by Country (2018-2023) & (US$ Million)
Table 47. Middle East & Africa Minimal Residual Disease (MRD) Testing Market Size by Country (2024-2033) & (US$ Million)
Table 48. Sysmex Corporation Company Detail
Table 49. Sysmex Corporation Business Overview
Table 50. Sysmex Corporation Minimal Residual Disease (MRD) Testing Product
Table 51. Sysmex Corporation Revenue in Minimal Residual Disease (MRD) Testing Business (2018-2023) & (US$ Million)
Table 52. Sysmex Corporation Recent Development
Table 53. Natera Company Detail
Table 54. Natera Business Overview
Table 55. Natera Minimal Residual Disease (MRD) Testing Product
Table 56. Natera Revenue in Minimal Residual Disease (MRD) Testing Business (2018-2023) & (US$ Million)
Table 57. Natera Recent Development
Table 58. Asuragen Company Detail
Table 59. Asuragen Business Overview
Table 60. Asuragen Minimal Residual Disease (MRD) Testing Product
Table 61. Asuragen Revenue in Minimal Residual Disease (MRD) Testing Business (2018-2023) & (US$ Million)
Table 62. Asuragen Recent Development
Table 63. Quest Diagnostics Company Detail
Table 64. Quest Diagnostics Business Overview
Table 65. Quest Diagnostics Minimal Residual Disease (MRD) Testing Product
Table 66. Quest Diagnostics Revenue in Minimal Residual Disease (MRD) Testing Business (2018-2023) & (US$ Million)
Table 67. Quest Diagnostics Recent Development
Table 68. Mission Bio Company Detail
Table 69. Mission Bio Business Overview
Table 70. Mission Bio Minimal Residual Disease (MRD) Testing Product
Table 71. Mission Bio Revenue in Minimal Residual Disease (MRD) Testing Business (2018-2023) & (US$ Million)
Table 72. Mission Bio Recent Development
Table 73. LabCorp Company Detail
Table 74. LabCorp Business Overview
Table 75. LabCorp Minimal Residual Disease (MRD) Testing Product
Table 76. LabCorp Revenue in Minimal Residual Disease (MRD) Testing Business (2018-2023) & (US$ Million)
Table 77. LabCorp Recent Development
Table 78. Guardant Health Company Detail
Table 79. Guardant Health Business Overview
Table 80. Guardant Health Minimal Residual Disease (MRD) Testing Product
Table 81. Guardant Health Revenue in Minimal Residual Disease (MRD) Testing Business (2018-2023) & (US$ Million)
Table 82. Guardant Health Recent Development
Table 83. NeoGenomics Laboratories Company Detail
Table 84. NeoGenomics Laboratories Business Overview
Table 85. NeoGenomics Laboratories Minimal Residual Disease (MRD) Testing Product
Table 86. NeoGenomics Laboratories Revenue in Minimal Residual Disease (MRD) Testing Business (2018-2023) & (US$ Million)
Table 87. NeoGenomics Laboratories Recent Development
Table 88. ARUP Laboratories Company Detail
Table 89. ARUP Laboratories Business Overview
Table 90. ARUP Laboratories Minimal Residual Disease (MRD) Testing Product
Table 91. ARUP Laboratories Revenue in Minimal Residual Disease (MRD) Testing Business (2018-2023) & (US$ Million)
Table 92. ARUP Laboratories Recent Development
Table 93. NeoGenomics , Inc Company Detail
Table 94. NeoGenomics , Inc Business Overview
Table 95. NeoGenomics , Inc Minimal Residual Disease (MRD) Testing Product
Table 96. NeoGenomics , Inc Revenue in Minimal Residual Disease (MRD) Testing Business (2018-2023) & (US$ Million)
Table 97. NeoGenomics , Inc Recent Development
Table 98. Opko Health Company Detail
Table 99. Opko Health Business Overview
Table 100. Opko Health Minimal Residual Disease (MRD) Testing Product
Table 101. Opko Health Revenue in Minimal Residual Disease (MRD) Testing Business (2018-2023) & (US$ Million)
Table 102. Opko Health Recent Development
Table 103. Bio-Rad Laboratories Company Detail
Table 104. Bio-Rad Laboratories Business Overview
Table 105. Bio-Rad Laboratories Minimal Residual Disease (MRD) Testing Product
Table 106. Bio-Rad Laboratories Revenue in Minimal Residual Disease (MRD) Testing Business (2018-2023) & (US$ Million)
Table 107. Bio-Rad Laboratories Recent Development
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Minimal Residual Disease (MRD) Testing Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Minimal Residual Disease (MRD) Testing Market Share by Type: 2022 VS 2033
Figure 3. Flow Cytometry Features
Figure 4. Polymerase Chain Reaction Features
Figure 5. Next-generation Sequencing Features
Figure 6. Liquid Biopsies Features
Figure 7. Global Minimal Residual Disease (MRD) Testing Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 8. Global Minimal Residual Disease (MRD) Testing Market Share by Application: 2022 VS 2033
Figure 9. Specialty Clinics Case Studies
Figure 10. Hospitals Case Studies
Figure 11. Research Institutions Case Studies
Figure 12. Minimal Residual Disease (MRD) Testing Report Years Considered
Figure 13. Global Minimal Residual Disease (MRD) Testing Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 14. Global Minimal Residual Disease (MRD) Testing Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 15. Global Minimal Residual Disease (MRD) Testing Market Share by Region: 2022 VS 2033
Figure 16. Global Minimal Residual Disease (MRD) Testing Market Share by Players in 2022
Figure 17. Global Top Minimal Residual Disease (MRD) Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Minimal Residual Disease (MRD) Testing as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Minimal Residual Disease (MRD) Testing Revenue in 2022
Figure 19. North America Minimal Residual Disease (MRD) Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 20. North America Minimal Residual Disease (MRD) Testing Market Share by Country (2018-2033)
Figure 21. United States Minimal Residual Disease (MRD) Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Canada Minimal Residual Disease (MRD) Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Europe Minimal Residual Disease (MRD) Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Europe Minimal Residual Disease (MRD) Testing Market Share by Country (2018-2033)
Figure 25. Germany Minimal Residual Disease (MRD) Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. France Minimal Residual Disease (MRD) Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. U.K. Minimal Residual Disease (MRD) Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Italy Minimal Residual Disease (MRD) Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Russia Minimal Residual Disease (MRD) Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Nordic Countries Minimal Residual Disease (MRD) Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Asia-Pacific Minimal Residual Disease (MRD) Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Asia-Pacific Minimal Residual Disease (MRD) Testing Market Share by Region (2018-2033)
Figure 33. China Minimal Residual Disease (MRD) Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Japan Minimal Residual Disease (MRD) Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. South Korea Minimal Residual Disease (MRD) Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Southeast Asia Minimal Residual Disease (MRD) Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. India Minimal Residual Disease (MRD) Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Australia Minimal Residual Disease (MRD) Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Latin America Minimal Residual Disease (MRD) Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Latin America Minimal Residual Disease (MRD) Testing Market Share by Country (2018-2033)
Figure 41. Mexico Minimal Residual Disease (MRD) Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Brazil Minimal Residual Disease (MRD) Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Middle East & Africa Minimal Residual Disease (MRD) Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Middle East & Africa Minimal Residual Disease (MRD) Testing Market Share by Country (2018-2033)
Figure 45. Turkey Minimal Residual Disease (MRD) Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Saudi Arabia Minimal Residual Disease (MRD) Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Sysmex Corporation Revenue Growth Rate in Minimal Residual Disease (MRD) Testing Business (2018-2023)
Figure 48. Natera Revenue Growth Rate in Minimal Residual Disease (MRD) Testing Business (2018-2023)
Figure 49. Asuragen Revenue Growth Rate in Minimal Residual Disease (MRD) Testing Business (2018-2023)
Figure 50. Quest Diagnostics Revenue Growth Rate in Minimal Residual Disease (MRD) Testing Business (2018-2023)
Figure 51. Mission Bio Revenue Growth Rate in Minimal Residual Disease (MRD) Testing Business (2018-2023)
Figure 52. LabCorp Revenue Growth Rate in Minimal Residual Disease (MRD) Testing Business (2018-2023)
Figure 53. Guardant Health Revenue Growth Rate in Minimal Residual Disease (MRD) Testing Business (2018-2023)
Figure 54. NeoGenomics Laboratories Revenue Growth Rate in Minimal Residual Disease (MRD) Testing Business (2018-2023)
Figure 55. ARUP Laboratories Revenue Growth Rate in Minimal Residual Disease (MRD) Testing Business (2018-2023)
Figure 56. NeoGenomics , Inc Revenue Growth Rate in Minimal Residual Disease (MRD) Testing Business (2018-2023)
Figure 57. Opko Health Revenue Growth Rate in Minimal Residual Disease (MRD) Testing Business (2018-2023)
Figure 58. Bio-Rad Laboratories Revenue Growth Rate in Minimal Residual Disease (MRD) Testing Business (2018-2023)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed